Our Annual Report is fresh off the press! Grünenthal's people have transformed our company over the last few years, uniquely positioning us to meet the increased demand for better pain treatments. 🌎 Our medicines today help more patients than ever before as we are growing our footprint in key pharmaceutical markets, especially in the United States 🧬 We advanced key R&D projects, creating one of the strongest pain-focused pipelines in the industry 📦 We ensured uninterrupted supply of medicines to patients in over 100 countries 💊 Through strategic acquisitions, we expanded our portfolio of established medicines This momentum put us in an excellent position to deliver outstanding business performance. Read more about our story of transformation in our Annual Report: https://bit.ly/3UklN84 #WeAreGrünenthal #WorldFreeofPain
Die Grünenthal Gruppe
Arzneimittelherstellung
Grünenthal ist ein weltweit führendes Unternehmen in der Behandlung von Schmerzen und verwandten Erkrankungen.
Info
Grünenthal ist ein weltweit führendes Unternehmen in der Behandlung von Schmerzen und verwandten Erkrankungen. Als forschendes, vollständig integriertes Pharmaunternehmen verfügen wir über eine langjährige Erfahrung in innovativer Schmerztherapie und der Entwicklung modernster Technologien für Patienten weltweit. Mit Innovationen wollen wir das Leben von Patienten verbessern. Wir setzen uns mit aller Kraft dafür ein, unsere Vision von einer Welt ohne Schmerzen zu verwirklichen. Grünenthal hat seine Konzernzentrale in Aachen und ist mit Gesellschaften in 27 Ländern in Europa, Lateinamerika und den Vereinigten Staaten vertreten. Unsere Produkte sind in ca. 100 Ländern erhältlich. Im Jahr 2023 beschäftigte Grünenthal rund 4.400 Mitarbeitende und erzielte einen Umsatz von 1,8 Milliarden Euro. Weitere Informationen finden Sie auf unserer Website www.grunenthal.com Jobs & Career: http://careers.grunenthal.com/ Impressum: https://www.grunenthal.com/en/footer-links/imprint Privacy Statement: https://www.grunenthal.com/en/footer-links/privacy-statement-social-media Dieses Unternehmensprofil wird von Global Communications verwaltet. Im Rahmen unserer Verpflichtung zu Transparenz und den in unserer digital ethics Charta dargelegten Grundsätzen möchte Grünenthal Sie darüber informieren, dass gelegentlich Technologien der generativen künstlichen Intelligenz eingesetzt werden, um die Inhalte dieses Kanals zu verbessern. Jeder Beitrag wurde vor der Veröffentlichung von einem Mitglied unseres Teams zur Qualitätssicherung überprüft und redigiert.
- Website
-
http://www.grunenthal.com
Externer Link zu Die Grünenthal Gruppe
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Aachen
- Art
- Privatunternehmen
- Gegründet
- 1946
Orte
-
Primär
Zieglerstr. 6
Aachen, 52078, DE
Beschäftigte von Die Grünenthal Gruppe
Updates
-
"Navigating the complexities of our business with integrity and responsibility is not just a goal; it's a mission," says Sebastian Köhler, our General Counsel and member of the Executive Board Team at Grünenthal. Since joining Grünenthal in 2018, Sebastian and his General Counsel Area team have relentlessly driven our robust governance framework – and it is being lived by the whole Grünenthal world. This has paid off. Grünenthal’s most recent external low-risk ESG rating puts us in the top 2% of the pharmaceuticals sub-industry. For Sebastian, a former professional basketball player and manager, the low-risk ESG rating still feels like a true “slam dunk”. We invite you to explore our Corporate Responsibility Report to learn more about our ESG initiatives and our Responsibility Programme. #WeAreGrünenthal #WorldFreeofPain
-
With the recent investment in our Chilean plant, we are now capable of 100% weight-controlled capsule filling, including individual identification for every capsule to ensure top precision and quality. We can accomodate up to three different products in a single capsule, as a contract manufacturing service for global markets. Our latest intermittent motion technology supports the filling of hard gelatin or vegetable capsules with powders, granules, pellets, tablets, mini-tablets, liquids, and pastes, ensuring the highest standards of flexibility and quality. For further information or collaboration opportunities, please reach out to us: https://bit.ly/4bmW57Z #CapsuleFilling #GrünenthalPRO #ContractManufacturing
-
"Get it right, make it safe" is the theme of this year's World Patient Safety Day. Join our colleague Maria as she takes you into her day-to-day work in drug safety and explains how careful data analysis enables us to provide patients and healthcare professionals with up-to-date safety information: https://bit.ly/3eTEGMK #WorldPatientSafetyDay #WorldFreeofPain
-
Chronic pain is a complex puzzle with many pieces—nociceptive, neuropathic, and nociplastic mechanisms that often intersect. We’ve taken on the challenge of breaking down the complex world of pain for every audience. In this episode, Dr. Jan Adams explains at a professional level. For kids: https://lnkd.in/eqAksK7U For adults: https://lnkd.in/ek4-n3g5 #PainAwarenessMonth #WorldFreeofPain
-
Congratulations to the 1,800 young talents who have graduated from RWTH Aachen University this year. We wish you every success on your professional and personal journey! There have never been more graduates from the various faculties than in this ninth edition of the event and we were delighted to support the 2024 graduation ceremony as one of the sponsors. We are particularly proud to have Johannes Lohmeyer, Lukas Carduck, Lea Ritgens, Nicholas Haak, Ömer Arslan and Philipp Pomykol with us to provide them a flying start to their careers through our Global Graduate Programme. If you also strive to kick-start your career working on impactful projects, have a look into our Global Graduate Programme and join us in our work towards a world free of pain! New positions will be announced beginning of November: https://bit.ly/3XwZxH5 #WeAreGrünenthal #WorldFreeofPain #GlobalGraduates #Graduation
-
Our five manufacturing sites are now powered by 100% clean, green electricity! From reducing our energy consumption by 7.7% in just one year to installing solar panels at our sites in Italy, Switzerland and Germany, we are taking bold steps to reduce our impact on the environment. A huge thank you to everyone who has helped us reach this milestone. Together we are proving that business success and sustainability can go hand in hand. Let's continue to push the boundaries of what's possible! #GreenFuture #RenewableElectricity #SustainableBusiness #WeAreGrünenthal
-
“I have close relatives who suffer from pain. I have in my mind that every product I touch here in the warehouse could be used by my mother, my sisters, my friends.” Meet Jessica, our Warehouse Manager based in Quito, Ecuador. Bringing her soccer team spirit to her leadership role, Jessica is ensuring excellence in every aspect of our operations. #WorldFreeofPain #PainAwarenessMonth
-
What makes a company attractive to investors? Andrew Duncan and Anna Carduck answer this question every day. Andrew is our Deputy Head of Treasury and Head of Investor Relations, and Anna is our Senior Investor Relations Manager. Together, they look after current investors in Grünenthal’s debt and potential new ones. Trust is the most important currency for investors. Only through trust can long-term, successful relationships between the capital markets and companies develop. Trust is created through reliability, transparency and a high degree of authenticity. This is why Andrew and Anna regularly inform the markets about Grünenthal's strategy, performance, and future prospects. They make our work tangible for investors and can explain why it is worthwhile for them to work with us towards our vision of a World Free of Pain. For Grünenthal, this is a decisive success factor as our vision can only be realised with the support of this community. #WeareGrünenthal #WorldFreeofPain
-
Did you know chronic pain affects 1 in 5 adults globally? In this new Science Explained episode, Dr. Jan Adams explains pain at an adult level. Learn about the difference between chronic and acute pain, and the profound impact pain has on patients and society. We’ve taken on the challenge of breaking down the complex world of pain for every audience. For kids, watch here: https://lnkd.in/eqAksK7U #PainAwarenessMonth #WorldFreeofPain
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Fremdfinanzierung300.000.000,00 $